From "acute AIDS" to "chronic AIDS": Body perception and surgical interventions in people living with HIV and AIDS;Transformações da "aids aguda" para a "aids crônica": Percepção corporal e intervenções cirúrgicas entre pessoas vivendo com HIV e aids

Ciencia e Saude Coletiva

Volumn 13, Issue 6, 2008, Pages 1841-1849

  De Alencar, Tatianna Meireles Dantas ^a   Nemes, Maria Ines Battistella ^a   Velloso, Marco Aurélio ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Interpsic

Author keywords

AIDS; Anti retroviral medication; Body perception; Chronic disease; Lipodystrophy; People living with HIV

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISEASE; ADULT; ARTICLE; BODY IMAGE; CHRONIC DISEASE; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACUTE DISEASE; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY IMAGE; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED;

EID: 53749088584     PISSN: 14138123     EISSN: 16784561     Source Type: Journal    
DOI: 10.1590/S1413-81232008000600019     Document Type: Article

References (29)

1. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43(1):27-34.
2. Brasil. Programa Nacional de DST/Aids. Legislação sobre DST e Aids no Brasil. Brasília: Ministério da Saúde; 2000.
3. Dourado I, Vera MA, Barreira D, Brito AM. Aids epidemic trends after the introduction of antiretroviral therapy in Brazil. Rev. Saúde Pública 2006; 40(Supl):9-17.
4. Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, Chequer P, Teixeira PR, Hearst N. Dramatic improvement in survival among adult Brazilian Aids Patients. AIDS 2003; 17:1675-1682.
5. World Health Organization. "Chronic conditions: the global burden" e "Chronic Diseases". [acessado 2005 Out 11]. Disponível em: http://www.who.int/chronic_conditions/burden/en/index.html
6. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000; 356:1423-1430.
7. Mauss M. As técnicas corporais. In: Mauss M. Sociologia e antropologia. Vol. 2. São Paulo: Epu/Edusp; 1974.
8. Clarke A. What is a chronic disease? The effects of a re-definition in HIV and AIDS. Social Science and Medicine 1994; 39(4):591-597.
9. Nemes MIB, Beaudoin J, Conway S, Kivumbi G, Skjelmerud A, Vogel U. Evaluation of WHO's contribution to "3 by 5". Geneva: World Health Organization; 2006.
10. Levi GC, Vitoria MA Fighting against AIDS: the Brazilian experience. Lancet 2002; 360(9348):1862-1865.
11. Okie S. Fighting HIV. Lessons from Brazil. Perspective. N Engl J Med [periódico na Internet] 2006 [acessado 2006 Out 12]; 354(19): [cerca de 4 p.]. Disponível em: http://www.NEJM.org
12. Parker R, organizador. Política, instituições e AIDS: enfrentando a epidemia no Brasil. Rio de Janeiro: Jorge Zahar/ABIA; 1997.
13. Alencar TDM. A vida crônica é novidade na aids: as transformações da aids aguda para a aids crônica, sob o ponto de vista dos pacientes [dissertação]. São Paulo (SP): Faculdade de Medicina, Universidade de São Paulo; 2006.
14. Puls RL, Carr A. Practical applications of the HIV lipodystrophy case definition. AIDS READ 2003; 13(10):480-493.
15. Blanch J, Rousaud A, Martínez E, De Lazzari E, Peri J-M, Milinkovic A, Perez-Cuevas J-B, Blanco J-L, Gatell J-M. Impact of Lipodystrophy on the Quality of Life of HIV-1-Infected Patients. J Acquir Immune Defic Syndr 2002; (31):404-407.
16. Miller J, Carr A, Emery S, Law M, Mallal S, Baker D, Smith D, Kaldor J, Cooper DA. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Medicine 2003; (4):293.
17. Lichtenstein KA, Ward DJ, Moorman AC, Delaney KM, Young B, Palella FJ Jr, Rhodes PH, Wood KC, Holmberg SD, HIV Outpatient Study Investigators. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001; (15):1389-1398.
18. Santos C, Felipe Y, Braga P, Ramos D, Lima R, Segurado A. Self-Perception of Body changes in persons living with HIV/AIDS: prevalence and associate factors. AIDS 2005; 19 (Suppl 4):14-21.
19. Nemes MIB, organizador. Avaliação da aderência ao tratamento por anti-retrovirais em usuários de ambulatórios do sistema público de assistência à AIDS no estado de São Paulo. Brasília: Ministério da Saúde; 2000.
20. Minayo MCS. O desafio do conhecimento: pesquisa qualitativa em saúde. São Paulo: Hucitec; Rio de Janeiro: Abrasco; 1992.
21. Martinez E, Garcia-Viejo MA, Blanch L, Gatell JM. Lipodystrophy syndrome in patients with HIV infection: quality of life issues. Drug Saf 2001; 24(3):157-166.
22. Chapman L. Body image and HIV: implications for support and care. AIDS Care 1998; 10 (Suppl 2): S179-187.
23. Persson A. Facing HIV: body shape change and the (in)visibility of illness. Med Anthropol 2005; 24(3):237-264.
24. Power R, Tate HL, McGill SM, Taylor C. A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sex Transm Infect 2003; 79:137-141.
25. GAPA-BA. [site na Internet]. [acessado 2005 Out 17]. Disponível em: http://www.gapabahia.org.br/boletin_34/rev34_2.html
26. Grupo Pela Vidda/SP. [site na Internet]. [acessado 2005 Nov 29] . Disponível em: http://www.aids.org.br/lipodistrofia.asp
27. Jones D. HIV facial lipoatrophy: causes and treatment options. Dermatol Surg 2005; 31:1519-1529.
28. Illich I. A expropriação da saúde: nêmesis da medicina. Rio de Janeiro: Nova Fronteira; 1975.
29. Schraiber LB. Medicina tecnológica e prática profissional contemporânea: novos desafios e outros dilemas [tese de livre docência]. São Paulo (SP): Faculdade de Medicina, USP; 1997.